SCHEMBL19810174

SCHEMBL19810174

CCOC(=O)C1=NOC(c2c(Cl)cccc2OS(C)(=O)=O)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
POLB P06746 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
HTT P42858 3/20 0.35
MAPT P10636 4/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
TP53 P04637 1/20 0.33
XBP1 P17861 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TLR9 Q9NR96 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16340432 0.86 CYP3A4 (0.37) CYP3A4CYP2C19PPARGPPARAHTT
SCHEMBL17293858 0.85 HPGD (0.33) PPARGPPARAHTTMAPTSMN1; SMN2
SCHEMBL16340401 0.84 HPGD (0.33) L3MBTL1PPARGPPARAHTTMAPT
SCHEMBL19275156 0.78
SCHEMBL5996915 0.78 ALDH1A1 (0.51) ALDH1A1L3MBTL1POLBCYP3A4CYP2C19
SCHEMBL5994480 0.77 ALDH1A1 (0.48) ALDH1A1L3MBTL1POLBCYP3A4CYP2C19
SCHEMBL21252638 0.76 NFE2L2 (0.31) ALDH1A1TDP1
SCHEMBL13075826 0.73 ALDH1A1 (0.47) ALDH1A1L3MBTL1POLBCYP3A4CYP2C19
SCHEMBL5835530 0.72 L3MBTL1 (0.41) ALDH1A1L3MBTL1POLBCYP3A4CYP2C19
SCHEMBL341388 0.71 ALDH1A1 (0.52) ALDH1A1L3MBTL1POLBCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107406394-B Process for the preparation of substituted phenylisoxazoline derivatives 拜耳作物科学股份公司 2021-09-03 CN disclosed
US-10604495-B2 Process for preparing substituted phenylisoxazoline derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-03-31 US disclosed
US-10604495-B2 Process for preparing substituted phenylisoxazoline derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-03-31 US disclosed
EP-3265446-B1 PROCESS FOR PREPARING SUBSTITUTED PHENYLISOXAZOLINE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2019-08-14 EP disclosed
EP-3265446-B1 PROCESS FOR PREPARING SUBSTITUTED PHENYLISOXAZOLINE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2019-08-14 EP disclosed
US-10189799-B2 Process for preparing substituted phenylisoxazoline derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-01-29 US disclosed
US-10189799-B2 Process for preparing substituted phenylisoxazoline derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-01-29 US disclosed
US-20190016691-A1 PROCESS FOR PREPARING SUBSTITUTED PHENYLISOXAZOLINE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-01-17 US disclosed
US-20190016691-A1 PROCESS FOR PREPARING SUBSTITUTED PHENYLISOXAZOLINE DERIVATIVES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-01-17 US disclosed
US-20180030002-A1 Process for preparing substituted phenylisoxazoline derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-02-01 US disclosed
US-20180030002-A1 Process for preparing substituted phenylisoxazoline derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-02-01 US disclosed
US-20180030002-A1 Process for preparing substituted phenylisoxazoline derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189799-B2 Process for preparing substituted phenylisoxazoline derivatives CYP3A7, CYP3A4, CYP4X1 ALDH1A1 1036/4885L3MBTL1 4856/4885POLB 1028/4885
US-10604495-B2 Process for preparing substituted phenylisoxazoline derivatives CYP3A7, CYP3A4, CYP4X1 ALDH1A1 1036/4885L3MBTL1 4856/4885POLB 1028/4885
US-20190016691-A1 PROCESS FOR PREPARING SUBSTITUTED PHENYLISOXAZOLINE DERIVATIVES CYP3A7, CYP3A4, CYP4X1 ALDH1A1 1036/4885L3MBTL1 4856/4885POLB 1028/4885
US-20180030002-A1 Process for preparing substituted phenylisoxazoline derivatives CYP3A7, CYP3A4, CYP4X1 ALDH1A1 1036/4885L3MBTL1 4856/4885POLB 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.